<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Fortune 500 Global &#187; Wyeth</title>
	<atom:link href="http://www.fortune500global.com/category/fortune-global-companies/pharmaceuticals/wyeth/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.fortune500global.com</link>
	<description>A leading Market Information Resource</description>
	<lastBuildDate>Thu, 09 Sep 2010 21:15:00 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Wyeth &#8211; Latest Company News</title>
		<link>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-latest-company-news/</link>
		<comments>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-latest-company-news/#comments</comments>
		<pubDate>Fri, 11 Sep 2009 18:54:43 +0000</pubDate>
		<dc:creator>fortune</dc:creator>
				<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[adverse drug reactions]]></category>
		<category><![CDATA[Company News]]></category>
		<category><![CDATA[david archer]]></category>
		<category><![CDATA[fda submissions]]></category>
		<category><![CDATA[menopausal women]]></category>
		<category><![CDATA[osteoporotic fractures]]></category>
		<category><![CDATA[prevention of osteoporosis]]></category>
		<category><![CDATA[treatment of osteoporosis]]></category>
		<category><![CDATA[wyeth pharmaceuticals]]></category>

		<guid isPermaLink="false">http://www.fortune500global.com/?p=1990</guid>
		<description><![CDATA[Ligand receives $250,000 from Wyeth
17 Oct 2007
The payment arises from an agreement between the two companies and reflects progress in the development of bazedoxifene, a selective estrogen receptor modulator. Bazedoxifene is a synthetic drug that was designed to reduce the risk of osteoporotic fractures while protecting breast and uterine tissues. Wyeth received an approvable letter [...]]]></description>
		<wfw:commentRss>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-latest-company-news/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Wyeth &#8211; Latest Company Comment</title>
		<link>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-latest-company-comment/</link>
		<comments>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-latest-company-comment/#comments</comments>
		<pubDate>Fri, 11 Sep 2009 18:52:30 +0000</pubDate>
		<dc:creator>fortune</dc:creator>
				<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[acute gastroenteritis]]></category>
		<category><![CDATA[dose regimen]]></category>
		<category><![CDATA[gastroenteritis in infants]]></category>
		<category><![CDATA[human rotavirus]]></category>
		<category><![CDATA[immunization schedules]]></category>
		<category><![CDATA[live attenuated vaccine]]></category>
		<category><![CDATA[national immunization]]></category>
		<category><![CDATA[rotarix]]></category>
		<category><![CDATA[rotavirus vaccine]]></category>

		<guid isPermaLink="false">http://www.fortune500global.com/?p=1987</guid>
		<description><![CDATA[GlaxoSmithKline: progress for Rotarix in key US market
15 Aug 2007
GlaxoSmithKline&#8217;s rotavirus vaccine has been accepted for review by the FDA.
The FDA has accepted GSK&#8217;s application for Rotarix for review. Rotarix, a live attenuated vaccine derived from the most common human rotavirus strain, is used in infants to prevent rotavirus gastroenteritis. Rotavirus infects nearly every child [...]]]></description>
		<wfw:commentRss>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-latest-company-comment/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Wyeth &#8211; Locations and Subsidiaries</title>
		<link>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-locations-and-subsidiaries/</link>
		<comments>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-locations-and-subsidiaries/#comments</comments>
		<pubDate>Fri, 11 Sep 2009 18:47:36 +0000</pubDate>
		<dc:creator>fortune</dc:creator>
				<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[giralda farms]]></category>
		<category><![CDATA[john wyeth]]></category>
		<category><![CDATA[laboratorios wyeth]]></category>
		<category><![CDATA[Locations]]></category>
		<category><![CDATA[rua alexandre dumas]]></category>
		<category><![CDATA[wyeth australia]]></category>
		<category><![CDATA[wyeth india]]></category>
		<category><![CDATA[wyeth pharma]]></category>
		<category><![CDATA[wyeth pharmaceuticals]]></category>

		<guid isPermaLink="false">http://www.fortune500global.com/?p=1985</guid>
		<description><![CDATA[Head Office
Wyeth
5 Giralda Farms
Madison
New Jersey 07940
USA
P:1 973 660 5000
www.wyeth.com
Other Locations and Subsidiaries




Wyeth   Pharmaceuticals (Canada)
50 Minthorn Boulevard
Markham
Ontario   L3T 7Y2
CAN


Wyeth (Mexico)
Avenida 1 de Mayo No 127
Col   San Andres Atoto
Naucalpan
Edo de Mexico
MEX




Laboratorios Wyeth-Whitehall
Rua Alexandre Dumas
2200 5th Floor
CEP 04717 910
Sao Paulo SP
BRA


Laboratorios Wyeth Avenida Suba No 95 66 Bogota    COL




Wyeth [...]]]></description>
		<wfw:commentRss>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-locations-and-subsidiaries/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Wyeth &#8211; Top Competitors</title>
		<link>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-top-competitors/</link>
		<comments>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-top-competitors/#comments</comments>
		<pubDate>Fri, 11 Sep 2009 18:38:47 +0000</pubDate>
		<dc:creator>fortune</dc:creator>
				<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[bristol myers squibb]]></category>
		<category><![CDATA[bristol myers squibb company]]></category>
		<category><![CDATA[Competitors]]></category>
		<category><![CDATA[merck co inc]]></category>
		<category><![CDATA[myers squibb company]]></category>
		<category><![CDATA[novadel pharma]]></category>
		<category><![CDATA[procter gamble company]]></category>
		<category><![CDATA[roche holding ag]]></category>
		<category><![CDATA[sanofi aventis]]></category>

		<guid isPermaLink="false">http://www.fortune500global.com/?p=1980</guid>
		<description><![CDATA[The following companies are the major competitors of Wyeth:

AstraZeneca PLC
Sanofi-Aventis Group
Bayer AG
Bristol-Myers Squibb Company
Eli Lilly and Company
Johnson &#38; Johnson
Merck &#38; Co., Inc.
Novartis AG
Pfizer Inc
Roche Holding AG
GlaxoSmithKline Plc
Procter &#38; Gamble Company,
The Millennium Pharmaceuticals
Barr Pharmaceuticals
Novo Nordisk A/S
NovaDel Pharma Inc


Tags:  Competitors,  myers squibb company,  bristol myers squibb company,  roche holding ag,  Wyeth,  [...]]]></description>
		<wfw:commentRss>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-top-competitors/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Wyeth &#8211; Major Products and Services</title>
		<link>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-major-products-and-services/</link>
		<comments>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-major-products-and-services/#comments</comments>
		<pubDate>Fri, 11 Sep 2009 18:31:32 +0000</pubDate>
		<dc:creator>fortune</dc:creator>
				<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[allergy remedies]]></category>
		<category><![CDATA[benefix]]></category>
		<category><![CDATA[growth implants]]></category>
		<category><![CDATA[immunological products]]></category>
		<category><![CDATA[parasite control]]></category>
		<category><![CDATA[Products and Services]]></category>
		<category><![CDATA[refacto]]></category>
		<category><![CDATA[tazocin]]></category>
		<category><![CDATA[zosyn]]></category>

		<guid isPermaLink="false">http://www.fortune500global.com/?p=1978</guid>
		<description><![CDATA[Wyeth is a research-based pharmaceutical and health care products company. The company&#8217;s products and services are categorized under the following different segments:
Pharmaceuticals:

Neuroscience therapies
Cardiovascular products
Nutritionals
Gastroenterology drugs
Anti-infectives Vaccines
Oncology therapies
Musculoskeletal therapies
Hemophilia treatments
Immunological products
Women&#8217;s healthcare products
Consumer healthcare:

Analgesics
Cough/cold/allergy remedies
Nutritional supplements
Hemorrhoidal treatments Asthma
and personal-care products

Animal health:

Pharmaceuticals
Vaccines
Parasite control
Growth implants

Brands:

Effexor
Protonix
Prevnar
Premarin
Zosyn
Tazocin
Enbrel
Zoton
BeneFIX
Rapamune
ReFacto
Ativan
Synvisc
Centrum
Advil
Robitussin
Caltrate
Advil Cold &#38; Sinus
ChapStick
Solgar
Dimetapp
Alavert


Tags:  immunological products,  Products and Services,  tazocin,  [...]]]></description>
		<wfw:commentRss>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-major-products-and-services/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Wyeth &#8211; Company View</title>
		<link>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-company-view/</link>
		<comments>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-company-view/#comments</comments>
		<pubDate>Mon, 07 Sep 2009 19:13:01 +0000</pubDate>
		<dc:creator>fortune</dc:creator>
				<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[Centrum]]></category>
		<category><![CDATA[challenge]]></category>
		<category><![CDATA[Company View]]></category>
		<category><![CDATA[Consumer]]></category>
		<category><![CDATA[growth]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[reformulation]]></category>
		<category><![CDATA[vaccine]]></category>
		<category><![CDATA[wyeth pharmaceuticals]]></category>

		<guid isPermaLink="false">http://www.fortune500global.com/?p=1982</guid>
		<description><![CDATA[A statement by Robert Essner, Chairman and Chief Executive Officer of Wyeth is given below. The statement has been taken from the company’s annual report 2006.
I am pleased to report that 2006 was an excellent year for Wyeth. Building on our strong performance in 2005, we once again delivered on our commitment to expand our [...]]]></description>
		<wfw:commentRss>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-company-view/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Wyeth &#8211; Key Facts</title>
		<link>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-key-facts/</link>
		<comments>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-key-facts/#comments</comments>
		<pubDate>Mon, 07 Sep 2009 18:52:52 +0000</pubDate>
		<dc:creator>fortune</dc:creator>
				<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[buenos aires]]></category>
		<category><![CDATA[fax web]]></category>
		<category><![CDATA[giralda farms]]></category>
		<category><![CDATA[Key Facts]]></category>
		<category><![CDATA[madison new jersey]]></category>
		<category><![CDATA[mexico city]]></category>
		<category><![CDATA[usa phone]]></category>
		<category><![CDATA[wye wyeth]]></category>

		<guid isPermaLink="false">http://www.fortune500global.com/?p=1925</guid>
		<description><![CDATA[



Head Office


Wyeth
5 Giralda Farms
Madison
New Jersey   07940
USA




Phone


1 973 660 5000




Fax







Web Address


www.wyeth.com




Revenue /   turnover (USD Mn)


20,350.7




Financial Year End


December




Employees


50,060




New York Ticker


WYE




Buenos Aires Ticker


WYE




Mexico City Stock Exchange Ticker


WYE






Tags:  fax web,  mexico city,  Wyeth,  Key Facts,  usa phone  

]]></description>
		<wfw:commentRss>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-key-facts/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Wyeth &#8211; Business Description</title>
		<link>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-business-description/</link>
		<comments>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-business-description/#comments</comments>
		<pubDate>Mon, 07 Sep 2009 18:51:24 +0000</pubDate>
		<dc:creator>fortune</dc:creator>
				<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[Business Description]]></category>
		<category><![CDATA[effexor xr]]></category>
		<category><![CDATA[ethical pharmaceuticals]]></category>
		<category><![CDATA[healthcare institutions]]></category>
		<category><![CDATA[healthcare segment]]></category>
		<category><![CDATA[hemophilia treatments]]></category>
		<category><![CDATA[immunological products]]></category>
		<category><![CDATA[wyeth consumer healthcare]]></category>
		<category><![CDATA[wyeth pharmaceuticals]]></category>

		<guid isPermaLink="false">http://www.fortune500global.com/?p=1927</guid>
		<description><![CDATA[Wyeth is engaged in the discovery, development, manufacture, distribution and sale of a diversified line of health care products. The company sells its line of products to wholesalers, pharmacies, hospitals, physicians, retailers and other healthcare institutions located in various markets in more than 145 countries.
The company has three primary business segments: pharmaceuticals, consumer healthcare and [...]]]></description>
		<wfw:commentRss>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-business-description/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Wyeth &#8211; History</title>
		<link>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-history/</link>
		<comments>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-history/#comments</comments>
		<pubDate>Mon, 07 Sep 2009 18:48:04 +0000</pubDate>
		<dc:creator>fortune</dc:creator>
				<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[animal health division]]></category>
		<category><![CDATA[animal health products]]></category>
		<category><![CDATA[conjugate vaccine]]></category>
		<category><![CDATA[diphtheria crm197 protein]]></category>
		<category><![CDATA[History]]></category>
		<category><![CDATA[human pharmaceuticals]]></category>
		<category><![CDATA[invasive pneumococcal disease]]></category>
		<category><![CDATA[john wyeth]]></category>
		<category><![CDATA[sherwood medical]]></category>

		<guid isPermaLink="false">http://www.fortune500global.com/?p=1930</guid>
		<description><![CDATA[Wyeth was founded in the 1860s as a small drugstore called John Wyeth and Brother. In 1931, American Home Products (AHP) purchased Wyeth from Harvard University, which had acquired a controlling interest in the firm from John Wyeth’s son and heir. Growth was fairly rapid and the company began to expand internationally. By 1944, the [...]]]></description>
		<wfw:commentRss>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-history/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Wyeth &#8211; Key Employees</title>
		<link>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-key-employees/</link>
		<comments>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-key-employees/#comments</comments>
		<pubDate>Mon, 07 Sep 2009 18:44:34 +0000</pubDate>
		<dc:creator>fortune</dc:creator>
				<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[chief information officer]]></category>
		<category><![CDATA[corporate business development]]></category>
		<category><![CDATA[corporate information services]]></category>
		<category><![CDATA[ivan g seidenberg]]></category>
		<category><![CDATA[john d feerick]]></category>
		<category><![CDATA[Key Employees]]></category>
		<category><![CDATA[robert essner]]></category>
		<category><![CDATA[robert langer]]></category>
		<category><![CDATA[vice president human resources]]></category>

		<guid isPermaLink="false">http://www.fortune500global.com/?p=1932</guid>
		<description><![CDATA[



Name


Job Title


Board




Robert   Essner


Chairman and Chief Executive Officer


Executive   Board




Bernard   Poussot


Vice   Chairman, President and Chief Operating Officer


Executive   Board




John   D Feerick


Director


Non   Executive Board




Frances   D Fergusson


Director


Non   Executive Board




Victor   F Ganzi


Director


Non   Executive Board




Robert   Langer


Director


Non   [...]]]></description>
		<wfw:commentRss>http://www.fortune500global.com/fortune-global-companies/pharmaceuticals/wyeth/wyeth-key-employees/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
